Portfolio Value Creation Program for PE-Backed Orthopedics Company
18 months | Portfolio value creation + embedded advisory
The Challenge
A PE-backed orthopedics platform company (EUR 200M revenue) was underperforming sponsor return expectations. Market share was stable but pricing power was limited, margins were declining, and geographic expansion plans were delayed. PE sponsor needed a structured approach to capturing commercial value across the portfolio.
Our Approach
We conducted a comprehensive commercial value creation assessment identifying 12 initiatives across pricing optimization, channel restructuring, key account development, and market expansion. We prioritized initiatives by impact and feasibility, embedded commercial leaders within the company to drive execution, and implemented quarterly performance tracking against value creation milestones. Focus areas included pricing architecture redesign, distributor consolidation, and new market entry in 3 countries.
Results
- Delivered EUR 28M incremental EBITDA in 18 months
- Achieved pricing improvement of 4.2% with 0 volume loss
- Expanded market share from 18% to 22% in core segments
- Entered 3 new markets with 12+ months ahead of plan
- Improved operational margins from 31% to 38%
- Supported successful exit at 8.8x EBITDA